SandboxAQ redefines drug discovery with a comprehensive approach powered by Large Quantitative Models (LQMs) combining AI and physics-based methods. From early research to clinical candidate selection, we accelerate the development of small molecules and biologics, delivering faster, accurate solutions to challenging problems. We provide an integrated solution throughout the drug discovery lifecycle and seamlessly integrate into our customer’s programs to enhance ability to generate novel molecular drug IP and clinical assets.  Our clients and partners include pharma, biotech, nonprofit organizations, and top academic institutions like Sanofi, Riboscience, the University of California San Francisco, the Michael J. Fox Foundation for Parkinson's Research, SPARK NS, KU Leuven, and Flagship Pioneering.